Advertisement
U.S. Markets open in 4 hrs 5 mins

Waverley Pharma Inc. (WAVE.V)

TSXV - TSXV Real Time Price. Currency in CAD
0.01500.0000 (0.00%)
At close: 01:36PM EDT
Advertisement
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
293.404
412.09
1,247
1,753
1,375
-
Cost of Revenue
215.42
332.289
963.043
1,530
1,193
-
Gross Profit
77.984
79.801
283.789
222.669
181.706
-
Operating Expense
1,212
1,314
921.945
1,009
891.307
-
Operating Income
-1,134
-1,234
-638.156
-786.826
-709.601
-
Net Non Operating Interest Income Expense
-97.377
-76.653
-16.638
-3.037
5.392
-
Other Income Expense
-917.043
-913.511
-9.282
-6.644
-1.554
-
Pretax Income
-2,149
-2,224
-664.076
-796.507
-705.763
-
Net Income Common Stockholders
-2,149
-2,224
-664.076
-796.507
-705.763
-
Diluted NI Available to Com Stockholders
-2,149
-2,224
-664.076
-796.507
-705.763
-
Basic EPS
-0.01
-0.04
-0.01
-0.01
-0.01
-
Diluted EPS
-0.01
-0.04
-0.01
-0.01
-0.01
-
Basic Average Shares
54,000
54,000
54,000
54,000
54,000
-
Diluted Average Shares
54,000
54,000
54,000
54,000
54,000
-
Total Expenses
1,428
1,646
1,885
2,540
2,085
-
Net Income from Continuing & Discontinued Operation
-2,149
-2,224
-664.076
-796.507
-705.763
-
Normalized Income
-1,202
-1,281
-654.794
-747.886
-692.428
-
Interest Income
-
-
-
-
5.392
45.993
Net Interest Income
-97.377
-76.653
-16.638
-3.037
5.392
-
EBIT
-1,138
-1,234
-638.156
-786.826
-709.601
-
EBITDA
-896.299
-911.979
-530.431
-758.66
-701.429
-
Reconciled Cost of Revenue
215.42
332.289
963.043
1,530
1,193
-
Reconciled Depreciation
241.429
321.905
107.725
28.166
8.172
-
Net Income from Continuing Operation Net Minority Interest
-2,149
-2,224
-664.076
-796.507
-705.763
-
Total Unusual Items Excluding Goodwill
-946.733
-943.201
-9.282
-48.621
-13.335
-
Total Unusual Items
-946.733
-943.201
-9.282
-48.621
-13.335
-
Normalized EBITDA
50.434
31.222
-521.149
-710.039
-688.094
-
Tax Rate for Calcs
0
0
0
0
0
-
Tax Effect of Unusual Items
0
0
0
0
0
-